文献速递呼吸衰竭与机械通气重症综合管理与镇静镇痛

静脉-静脉体外膜氧合中的血液创伤:低泵压与低回路阻力至关重要

Blood trauma in veno-venous extracorporeal membrane oxygenation: low pump pressures and low circuit resistance matter.
PubMed 文献 · Crit Care · 2024-10-08
一句话结论VV ECMO中低泵压和低回路阻力与最小溶血相关,高泵压和高回路阻力则一致导致显著溶血,降低回路阻力(低阻力氧合器、最短管路、合适直径插管)可能是减少ECMO支持副反应的关键因素。

该研究结合580例接受VV ECMO治疗患者的临床数据与Rotaflow(Getinge)和DP3(Xenios)泵的计算流体动力学及降阶模型溶血预测,分析94,779个泵工作点的血液创伤参数与剪切诱导溶血数值预测的关联。结果显示,在所有流量下,低泵压和低回路阻力时溶血最小,而高泵压和高回路阻力一致导致显著溶血,且流量越低回路阻力对溶血的影响越明显。数值模型经临床数据验证,模拟与观察溶血之间呈强关联(Spearman r=0.8),与泵类型无关。作者认为,维持低回路阻力(包括尽可能低阻力的氧合器、最短可行管路和最佳直径插管)是降低ECMO支持副反应的关键因素。

要点

  • 在所有流量下,低泵压和低回路阻力时溶血最小,高泵压和高回路阻力一致导致显著溶血。
  • 流量越低,回路阻力对溶血的影响越明显。
  • 数值模型经580例VV ECMO患者临床数据验证,模拟与观察溶血呈强关联(Spearman r=0.8),与泵类型无关。
  • 作者认为,降低ECMO支持副反应的关键因素是维持低回路阻力,包括尽可能低阻力的氧合器、最短可行管路和最佳直径插管。

适用人群与场景

  • 接受静脉-静脉体外膜氧合(VV ECMO)治疗的患者,临床数据来自580例接受VV ECMO治疗的患者。

研究设计与关键结果

  • 研究类型:结合计算机模拟(计算流体动力学和降阶模型)与临床数据分析。
  • 样本量:580例接受VV ECMO治疗的患者;分析94,779个泵工作点。
  • 设备:Rotaflow(Getinge)和DP3(Xenios)泵。
  • 主要结果:在所有流量下,低泵压和低回路阻力时观察到最小溶血;高泵压和高回路阻力一致导致显著溶血,与流量无关;流量越低,回路阻力对溶血的影响越明显。
  • 模型验证:数值模型经临床数据验证,模拟与观察溶血之间呈强关联(Spearman r=0.8),与泵类型无关。

证据类型、等级与局限

  • 证据类型:结合计算机模拟与临床数据分析的研究。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 作者认为,降低ECMO支持副反应的关键因素是维持低回路阻力,包括使用尽可能低阻力的氧合器、最短可行管路和最佳直径插管。
  • 作者认为,将计算机模拟预测与临床数据整合为了解并可能减少VV ECMO中的血液创伤提供了新方法。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

BACKGROUND: Veno-venous extracorporeal membrane oxygenation (VV ECMO) has become standard of care in patients with the most severe forms of acute respiratory distress syndrome. However, hemolysis and bleeding are one of the most frequent side effects, affecting mortality. Despite the widespread use of VV ECMO, current protocols lack detailed, in-vivo data-based recommendations for safe ECMO pump operating conditions. This study aims to comprehensively analyze the impact of VV ECMO pump operating conditions on hemolysis by combining in-silico modeling and clinical data analysis.

METHODS: We combined data from 580 patients treated with VV ECMO in conjunction with numerical predictions of hemolysis using computational fluid dynamics and reduced order modeling of the Rotaflow (Getinge) and DP3 (Xenios) pumps. Blood trauma parameters across 94,779 pump operating points were associated with numerical predictions of shear induced hemolysis.

RESULTS: Minimal hemolysis was observed at low pump pressures and low circuit resistance across all flow rates, whereas high pump pressures and circuit resistance consistently precipitated substantial hemolysis, irrespective of flow rate. However, the lower the flow rate, the more pronounced the influence of circuit resistance on hemolysis became. Numerical models validated against clinical data demonstrated a strong association (Spearman's r = 0.8) between simulated and observed hemolysis, irrespective of the pump type.

CONCLUSIONS: Integrating in-silico predictions with clinical data provided a novel approach in understanding and potentially reducing blood trauma in VV ECMO. This study further demonstrated that a key factor in lowering side effects of ECMO support is the maintenance of low circuit resistance, including oxygenators with the lowest possible resistance, the shortest feasible circuit tubing, and cannulae with an optimal diameter.

来源:Crit Care,查看原文。版权归原作者所有。

参考来源

  1. Blum C, Landoll M, Strassmann SE, et al. Blood trauma in veno-venous extracorporeal membrane oxygenation: low pump pressures and low circuit resistance matter. Crit Care. 2024. PMID: 39380050. doi:10.1186/s13054-024-05121-9

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。